Rxivist logo

The landscape of incident disease risk for the biomarker GlycA and its mortality stratification in angiography patients

By Johannes Kettunen, Scott C Ritchie, Olga Anufrieva, Leo-Pekka Lyytikäinen, Jussi Hernesniemi, Pekka J. Karhunen, Pekka Kuukasjärvi, Jari Laurikka, Mika Kähönen, Terho Lehtimäki, Aki S Havulinna, Veikko Salomaa, Satu Männistö, Mika Ala-Korpela, Markus Perola, Michael Inouye, Peter Würtz

Posted 12 Mar 2018
bioRxiv DOI: 10.1101/280677 (published DOI: 10.1161/CIRCGEN.118.002234)

Integration of systems-level biomolecular information with electronic health records has led to the discovery of robust blood-based biomarkers predictive of future health and disease. Of recent intense interest is the GlycA biomarker, a complex nuclear magnetic resonance (NMR) spectroscopy signal reflective of acute and chronic inflammation, which predicts long term risk of diverse outcomes including cardiovascular disease, type 2 diabetes, and all-cause mortality. To systematically explore the specificity of the disease burden indicated by GlycA we analysed the risk for 468 common incident hospitalization and mortality outcomes occurring during an 8-year follow-up of 11,861 adults from Finland. Our analyses of GlycA replicated known associations, identified associations with specific cardiovascular disease outcomes, and uncovered new associations with risk of alcoholic liver disease (meta-analysed hazard ratio 2.94 per 1-SD, P=5 10-6), chronic renal failure (HR=2.47, P=3 10-6), glomerular diseases (HR=1.95, P=1 10-6), chronic obstructive pulmonary disease (HR=1.58, P=3 10-5), inflammatory polyarthropathies (HR=1.46, P=4 10-8), and hypertension (HR=1.21, P=5 10-5). We further evaluated GlycA as a biomarker in secondary prevention of 12-year cardiovascular mortality in 900 angiography patients with suspected coronary artery disease. We observed hazard ratios of 4.87 and 5.00 for 12-year mortality in angiography patients in the fourth and fifth quintiles by GlycA levels demonstrating the prognostic potential of GlycA for identification of high mortality-risk individuals. Both GlycA and C-reactive protein had shared as well as independent contributions to mortality hazard, emphasising the importance of chronic inflammation in secondary prevention of cardiovascular disease.

Download data

  • Downloaded 466 times
  • Download rankings, all-time:
    • Site-wide: 58,707
    • In epidemiology: 2,542
  • Year to date:
    • Site-wide: 93,075
  • Since beginning of last month:
    • Site-wide: 59,304

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide